Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
British Journal of Cancer
|
March 13, 2014
Comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
D Tougeron, P Laurent-Puig, A Zaanan
Gastroenterologie Clinique Et Biologique
|
June 12, 2010
[Small bowel adenocarcinoma]
A Zaanan, P Afchain, N Carrere, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2019
Immunotherapy in advanced gastric cancer, is it the future?
C Coutzac, S Pernot, N Chaput, et al.
ESMO Gastrointestinal Oncology
|
June 12, 2026
Checkpoint inhibitors in microsatellite instability-high metastatic colorectal cancer: treatment strategies, specificities, and care management questions
T André, S Lonardi, A Zaanan, et al.
Clinical Pharmacology and Therapeutics
|
September 17, 2013
A case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variant
A Zaanan, L-M Dumont, M-A Loriot, et al.
La Revue De Medecine Interne
|
December 25, 2019
[A diffuse rash]
D Vétois, C Lheure, E Rosencher, et al.
ESMO Open
|
October 26, 2024
Encorafenib, binimetinib and cetuximab in BRAF V600E-mutated advanced pancreatic adenocarcinoma
A Zaanan, V Dabout, S Garinet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy
E Auclin, A Zaanan, D Vernerey, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations
C Soueidy, A Zaanan, M Gelli, et al.
Oncogene
|
June 12, 2013
Involvement of small ArfGAP1 (SMAP1), a novel Arf6-specific GTPase-activating protein, in microsatellite instability oncogenesis
F Sangar, A-S Schreurs, C Umaña-Diaz, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
British Journal of Cancer
|
March 13, 2014
Comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
D Tougeron, P Laurent-Puig, A Zaanan
Gastroenterologie Clinique Et Biologique
|
June 12, 2010
[Small bowel adenocarcinoma]
A Zaanan, P Afchain, N Carrere, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2019
Immunotherapy in advanced gastric cancer, is it the future?
C Coutzac, S Pernot, N Chaput, et al.
ESMO Gastrointestinal Oncology
|
June 12, 2026
Checkpoint inhibitors in microsatellite instability-high metastatic colorectal cancer: treatment strategies, specificities, and care management questions
T André, S Lonardi, A Zaanan, et al.
Clinical Pharmacology and Therapeutics
|
September 17, 2013
A case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variant
A Zaanan, L-M Dumont, M-A Loriot, et al.
La Revue De Medecine Interne
|
December 25, 2019
[A diffuse rash]
D Vétois, C Lheure, E Rosencher, et al.
ESMO Open
|
October 26, 2024
Encorafenib, binimetinib and cetuximab in BRAF V600E-mutated advanced pancreatic adenocarcinoma
A Zaanan, V Dabout, S Garinet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy
E Auclin, A Zaanan, D Vernerey, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations
C Soueidy, A Zaanan, M Gelli, et al.
Oncogene
|
June 12, 2013
Involvement of small ArfGAP1 (SMAP1), a novel Arf6-specific GTPase-activating protein, in microsatellite instability oncogenesis
F Sangar, A-S Schreurs, C Umaña-Diaz, et al.
Page
of 3